Δευτέρα 2 Ιουλίου 2018

Chimeric Antigen Receptor Therapy

The aim of cancer immunotherapy is to enhance the immune response against tumor cells. The emergence of immuno-oncology as the first broadly successful strategy to treat metastatic cancer will require clinicians to integrate this new type of medicine with chemotherapy, surgery, radiation therapy,…

https://ift.tt/2KAdt0Z

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου